WallStreetZenWallStreetZen

NASDAQ: ACAD
Acadia Pharmaceuticals Inc Stock Ownership - Who owns Acadia Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Acadia Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
James KiharaPrincipal Accounting Officer2023-09-152,000$25.88
$51.76kSell
Mark C. SchneyerEVP Chief Financial Officer2023-08-2110,000$29.00
$289.97kSell
Stephen DavisCEO2023-07-14100,000$30.04
$3.00MSell
Stephen DavisCEO2023-07-14100,000$20.77
$2.08MBuy
Stephen DavisCEO2023-07-1255,104$25.05
$1.38MSell
Stephen DavisCEO2023-07-1116,498$25.00
$412.45kSell
James KiharaPrincipal Accounting Officer2023-06-152,000$24.15
$48.30kSell
Laura BregeDirector2023-06-124,500$24.87
$111.91kSell
Mark C. SchneyerEVP Chief Financial Officer2023-06-08974$25.02
$24.37kSell
Baker Bros Advisors LPDirector2023-05-2428,878$25.51
$736.79kBuy

1 of 6

ACAD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACAD insiders and whales buy or sell their stock.

ACAD Shareholders

What type of owners hold Acadia Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP26.18%42,864,612$922.88MInstitution
Baker Bros Advisors LP24.08%39,433,853$849.01MInsider
Baker Brothers Life Sciences LP8.69%14,229,612$306.36MInsider
Vanguard Group Inc8.46%13,854,846$298.29MInstitution
Blackrock Inc6.13%10,039,501$216.15MInstitution
Rtw Investments LP5.98%9,783,249$210.63MInstitution
Price T Rowe Associates Inc3.67%6,013,914$129.48MInstitution
Ecor1 Capital LLC3.66%5,991,479$129.00MInstitution
State Street Corp3.31%5,420,318$116.70MInstitution
Fmr LLC3.25%5,321,237$114.57MInstitution

1 of 3

ACAD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACAD71.05%28.95%Net BuyingNet Selling
CERE25.82%74.18%Net SellingNet Buying
FOLD65.52%34.48%Net SellingNet Selling
AXSM69.64%30.36%Net SellingNet Selling
MLTX78.68%21.32%Net Buying
View Top Biotech Stocks

Acadia Pharmaceuticals Stock Ownership FAQ

Who owns Acadia Pharmaceuticals?

Acadia Pharmaceuticals (NASDAQ: ACAD) is owned by 96.29% institutional shareholders, 39.23% Acadia Pharmaceuticals insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Acadia Pharmaceuticals shareholder, owning 39.43M shares representing 24.08% of the company. Baker Bros Advisors LP's Acadia Pharmaceuticals shares are currently valued at $821.80M.

If you're new to stock investing, here's how to buy Acadia Pharmaceuticals stock.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.